MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, JAGX made $20,272K in revenue. -$7,015K in net income. Net profit margin of -34.60%.

Income Overview

Revenue
$20,272K
Net Income
-$7,015K
Net Profit Margin
-34.60%
EPS
-$13.6
Unit: Thousand (K) dollars
Revenue Breakdown
    • Human Health Segment
    • Animal Health Segment
Revenue Breakdown
    • License
    • Product
    • Grant

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue, net
20,272 3,235 3,083 2,979
Cost of product revenue
1,158 2,200 532 527
Research and development
3,928 14,313 3,658 3,265
Sales and marketing
896 2,278 1,997 2,467
General and administrative
4,108 4,886 4,134 4,727
Impairment loss on indefinite-lived intangible assets
-800 --
Total operating expenses
10,090 24,477 10,321 10,986
Income (loss) from operations
10,182 -21,242 -7,238 -8,007
Interest income (expense)
699 132 6 -15
Gain on extinguishment of debt
-628 23 --1,822
Changes in fair value of freestanding and hybrid financial instruments designated at fair value option
337 1,545 2,310 1,068
Other income (expense)
205 -297 -94 322
Income (loss) before income tax expense
8,723 -23,193 -9,648 -10,560
Income tax expense
0 0 --
Net income (loss)
8,723 -23,193 -9,648 -10,560
Net loss attributable to noncontrolling interest
-126 -183* --
Stock dividends to preferred stockholders
9,470 ---
Deemed dividend to preferred stockholders
6,063 35* --
Net loss attributable to common stockholders
--23,045* --
Translation adjustments
--91* --
Preferred returns to preferred stockholders
331 ---
Net comprehensive loss attributable to common stockholders
--23,137 --
Net loss attributable to common stockholders
-7,015 ---
Basic EPS
-13.6 -9.92 -6.28 -10.26
Diluted EPS
-13.6 -9.92 -6.28 -10.26
Basic Average Shares
515,788 2,332,401* 1,513,178 1,014,783
Diluted Average Shares
515,788 2,332,401* 1,513,178 1,014,783
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Human Health Segment$19,927K (832.04%↑ Y/Y)Animal Health Segment$345K (353.95%↑ Y/Y)Total revenue, net$20,272K (815.63%↑ Y/Y)Income (loss) fromoperations$10,182K (208.08%↑ Y/Y)Other income(expense)$205K (83.04%↑ Y/Y)Total operatingexpenses$10,090K (-13.28%↓ Y/Y)Income (loss) beforeincome tax expense$8,723K (182.32%↑ Y/Y)Interest income(expense)$699K (1348.21%↑ Y/Y)Gain onextinguishment of debt-$628K Changes in fair value offreestanding and hybrid...$337K (-74.91%↓ Y/Y)General andadministrative$4,108K (-16.11%↓ Y/Y)Research and development$3,928K (5.31%↑ Y/Y)Cost of productrevenue$1,158K (124.85%↑ Y/Y)Sales and marketing$896K (-64.06%↓ Y/Y)Net lossattributable to common...-$7,015K Net income (loss)$8,723K (182.32%↑ Y/Y)Net lossattributable to...-$126K Stock dividends topreferred stockholders$9,470K Deemed dividend topreferred stockholders$6,063K Preferred returns topreferred stockholders$331K

Jaguar Health, Inc. (JAGX)

Jaguar Health, Inc. (JAGX)